These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin. Portha B; Serradas P Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320 [TBL] [Abstract][Full Text] [Related]
28. Effects of hyperinsulinemia and hyperglycemia on insulin receptor function and glycogen synthase activation in skeletal muscle of normal man. Bak JF; Møller N; Schmitz O; Richter EA; Pedersen O Metabolism; 1991 Aug; 40(8):830-5. PubMed ID: 1907347 [TBL] [Abstract][Full Text] [Related]
29. Intracellular defects in glucose metabolism in obese patients with NIDDM. Kelley DE; Mokan M; Mandarino LJ Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397 [TBL] [Abstract][Full Text] [Related]
31. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019 [TBL] [Abstract][Full Text] [Related]
32. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus. Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778 [TBL] [Abstract][Full Text] [Related]
33. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE; Matthews DR Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [TBL] [Abstract][Full Text] [Related]
34. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Friedman JE; Caro JF; Pories WJ; Azevedo JL; Dohm GL Metabolism; 1994 Aug; 43(8):1047-54. PubMed ID: 8052146 [TBL] [Abstract][Full Text] [Related]
35. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related]
36. Reversal of insulin resistance in adipose tissue of non-insulin-dependent diabetics by treatment with diet and sulphonylurea. Bolinder J; Ostman J; Arner P Acta Endocrinol (Copenh); 1985 Jan; 108(1):85-90. PubMed ID: 3918399 [TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604 [TBL] [Abstract][Full Text] [Related]
38. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. Kashiwagi A; Verso MA; Andrews J; Vasquez B; Reaven G; Foley JE J Clin Invest; 1983 Oct; 72(4):1246-54. PubMed ID: 6355180 [TBL] [Abstract][Full Text] [Related]
39. Fat cells: model system to investigate molecular mechanism(s) of sulfonylurea-potentiated glucose transport. Jacobs DB Am J Med; 1985 Sep; 79(3B):59-66. PubMed ID: 3931463 [TBL] [Abstract][Full Text] [Related]
40. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Olefsky JM; Garvey WT; Henry RR; Brillon D; Matthaei S; Freidenberg GR Am J Med; 1988 Nov; 85(5A):86-105. PubMed ID: 3057897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]